Stocks and Investing Stocks and Investing
Thu, February 28, 2019
Wed, February 27, 2019

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $65 on, Feb 27th, 2019


Published on 2024-10-26 12:19:13 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $67 to $65 on, Feb 27th, 2019.

Matthew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Kristen Stewart of "Barclays" Downgraded from Hold to Sell and Decreased Target to $36 on, Friday, January 4th, 2019
Contributing Sources